A malignant tumor that arises from hepatocytes. Hepatocellular carcinoma is relatively rare in the United States but very common in all African countries south of the Sahara and in Southeast Asia. Most cases are seen in patients over the age of 50 years, but this tumor can also occur in younger individuals and even in children. Hepatocellular carcinoma is more common in males than females and is associated with hepatitis B, hepatitis C, chronic alcohol abuse and cirrhosis. Serum elevation of alpha-fetoprotein occurs in a large percentage of patients with hepatocellular carcinoma. Grossly, hepatocellular carcinoma may present as a single mass, as multiple nodules, or as diffuse liver involvement. Microscopically, there is a wide range of differentiation from tumor to tumor (well differentiated to poorly differentiated tumors). Hepatocellular carcinomas quickly metastasize to regional lymph nodes and lung. The overall median survival of untreated liver cell carcinoma is about 4 months. The most effective treatment of hepatocellular carcinoma is complete resection of the tumor. Lately, an increasing number of tumors have been treated with liver transplantation. [ NCIT:C3099 ]
Synonyms: hepatocellular cancer, somatic hepatoblastoma, somatic hepatocellular adenocarcinoma hepatoma HCC primary carcinoma of the liver cells primary carcinoma of liver cells carcinoma of liver cancer, hepatocellular liver cell carcinoma liver cell cancer (hepatocellular carcinoma) carcinoma of liver cells liver carcinoma hepatocellular carcinoma, childhood type, somatic carcinoma of the liver cells hepatocellular carcinoma, somatic hepatocellular cancer hepatocellular carcinoma carcinoma, hepatocellular, malignant
Term information
- icd11.foundation:1294035808 (https://orcid.org/0000-0001-5208-3432)
- NORD:1907 (MONDO:NORD)
- MESH:D006528 (Orphanet:88673/e)
- NCIT:C3099 (MONDO:equivalentTo)
- MEDGEN:389187 (MONDO:equivalentTo)
- ONCOTREE:HCC (MONDO:equivalentTo)
- Orphanet:88673 (OMIM:114550)
- GARD:16773 (MONDO:GARD)
- DOID:684 (MONDO:equivalentTo)
- EFO:0000182 (MONDO:equivalentTo)
- NANDO:2200047 (https://orcid.org/0000-0003-0011-764X)
- DOID:686 (MONDO:equivalentTo)
- OMIM:114550 (Orphanet:88673/e)
- ICDO:8170/3 (NCIT:C3099)
- UMLS:C2239176 (MONDO:equivalentTo)
- MedDRA:10049010 (Orphanet:88673/e)
gard_rare, otar, rare, nord_rare, ordo_group_of_disorders
http://purl.obolibrary.org/obo/NCIT_C3099
https://omim.org/entry/114550
http://purl.obolibrary.org/obo/DOID_686
http://purl.obolibrary.org/obo/DOID_684
http://identifiers.org/medgen/389187
http://linkedlifedata.com/resource/umls/id/C2239176
http://identifiers.org/mesh/D006528
http://www.orpha.net/ORDO/Orphanet_88673
hepatoblastoma
liver and intrahepatic bile duct carcinoma
hepatoblastoma caused by somatic mutation
liver cancer